Metagenomic next-generation sequencing can pinpoint pathogens causing infections in patients with immune function challenges and complex conditions, potentially saving lives as well as lowering care costs. Charles Chiu, MD, PhD, explains the benefits and limitations of SURPI (sequence-based ultra-rapid pathogen identification), including when to consider its use and how results can guide treatment decisions.
Professor, Laboratory Medicine
Charles Chiu, M.D./Ph.D. is a Professor of Laboratory Medicine and Medicine, Division of Infectious Diseases at University of California, San Francisco.